Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350531
Max Phase: Preclinical
Molecular Formula: C23H39IN7O15P3
Molecular Weight: 873.42
Molecule Type: Small molecule
Associated Items:
ID: ALA3350531
Max Phase: Preclinical
Molecular Formula: C23H39IN7O15P3
Molecular Weight: 873.42
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CI)NCCCCC(=O)NCCCCCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C23H39IN7O15P3/c24-11-17(33)26-9-6-3-7-16(32)25-8-4-1-2-5-10-27-21-18-22(29-13-28-21)31(14-30-18)23-20(35)19(34)15(44-23)12-43-48(39,40)46-49(41,42)45-47(36,37)38/h13-15,19-20,23,34-35H,1-12H2,(H,25,32)(H,26,33)(H,39,40)(H,41,42)(H,27,28,29)(H2,36,37,38)/t15-,19-,20-,23-/m1/s1
Standard InChI Key: HTBRDLJBDVCJND-NSOPBCBCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 873.42 | Molecular Weight (Monoisotopic): 873.0762 | AlogP: 0.60 | #Rotatable Bonds: 22 |
Polar Surface Area: 323.34 | Molecular Species: ACID | HBA: 16 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.90 | CX Basic pKa: 4.74 | CX LogP: -3.74 | CX LogD: -8.87 |
Aromatic Rings: 2 | Heavy Atoms: 49 | QED Weighted: 0.03 | Np Likeness Score: 0.57 |
1. Hampton A, Patel AD, Chawla RR, Kappler F, Hai TT.. (1982) Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases., 25 (4): [PMID:7040662] [10.1021/jm00346a011] |
Source(1):